Sinsin Pharmaceutical Co., Ltd
Research Sinsin Pharmaceutical Co., Ltd (002800.KQ) on Bullrun: market cap KRW 65.38B, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker002800.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 65.38B
- Dividend yield1.9%
- Financial periodQ2 2026
- RevenueKRW 34.00B
- Net incomeKRW 3.68B
- Free cash flowKRW 741.48M
- Gross margin39.8%
Valuation Snapshot
latest market cap is KRW 65.38B; dividend yield is 1.9%.
Peer valuation comparison
Latest dividend yield is 1.86% versus a Healthcare sector median of 2.4% (22.5% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 65.38B | n/a | 1.9% | 80 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 80 KRW, yield 1.9%.
About Sinsin Pharmaceutical Co., Ltd
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sinsin Pharmaceutical Co., Ltd's market cap?
Sinsin Pharmaceutical Co., Ltd's market capitalization is KRW 65.38B.
Does Sinsin Pharmaceutical Co., Ltd pay a dividend?
Sinsin Pharmaceutical Co., Ltd has a dividend yield of 1.9%.
What does Sinsin Pharmaceutical Co., Ltd do?
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide.